Novartis AG Cash Flows From Used In Operating Activities Discontinued Operations
Novartis AG (NVS) reported Cash Flows From Used In Operating Activities Discontinued Operations of $238.00 million for the 12-month period ending 2023-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-02-04
- Novartis AG cash flows from used in operating activities discontinued operations for the quarter ending 2023-06-30 was $59.00M.
- Novartis AG cash flows from used in operating activities discontinued operations for the quarter ending 2018-06-30 was $430.00M.
| Period end | Cash Flows From Used In Operating Activities Discontinued Operations 3 month | Cash Flows From Used In Operating Activities Discontinued Operations 6 month | Cash Flows From Used In Operating Activities Discontinued Operations 12 month |
|---|---|---|---|
| 2023-12-31 | $238.00M 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $59.00M 6-K · filed 2024-07-18 | $164.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | $1.20B 20-F · filed 2025-01-31 | ||
| 2021-12-31 | $1.71B 20-F · filed 2024-01-31 | ||
| 2019-12-31 | $78.00M 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $78.00M 6-K · filed 2020-07-21 | ||
| 2018-12-31 | $1.22B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $430.00M 6-K · filed 2019-07-18 | $563.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | $1.20B 20-F · filed 2020-01-29 | ||
| 2015-12-31 | -$188.00M 6-K · filed 2018-01-24 |